Key Players in Thailand Gastroparesis Market | Competitive Landscape 2026

Key Players in Thailand Gastroparesis Market

Thailand gastroparesis market is undergoing significant growth, driven by rising prevalence of diabetic and idiopathic gastroparesis, increasing awareness of digestive health, and expanding access to advanced gastrointestinal therapies. Key players in this market include Takeda, Abbott, Pfizer and Novartis.

Thailand Gastroparesis Market Overview

According to 6Wresearch, the Thailand gastroparesis market is experiencing significant growth due to rising prevalence of diabetic and idiopathic gastroparesis, increasing awareness about gastrointestinal disorders, and the adoption of novel prokinetic therapies. Market growth is also supported by the availability of advanced diagnostic tools, government initiatives to improve digestive health, and increasing access to specialized gastroenterology care.

Competitive Landscape

The competitive landscape in the Thailand gastroparesis market is a mix of global pharmaceutical leaders and regional distributors. These companies provide a diverse product portfolio, ranging from prokinetic drugs, antiemetics, nutritional supplements, and advanced therapeutic solutions for managing chronic gastroparesis.

Leading Players Operating in the Thailand Gastroparesis Market:

1. Takeda Pharmaceutical Company Limited

A global pioneer in the managed motility segment, Takeda provides sophisticated gastrointestinal solutions that handle complex digestive compliance and large-scale patient management through innovative motility agents.

2. AstraZeneca PLC

A major force in the global digestive space, AstraZeneca focuses on multi-country compliance and AI-driven automation for screening chronic gastric complications in large-scale diabetic populations.

3. Abbott Laboratories

A historic innovator in tech and nutrition, Abbott is renowned for being among the first to offer localized enteral nutrition and digestive health solutions for small and medium hospital enterprises.

4. Siam Pharmaceutical Co., Ltd.

A fast-growing leader in the domestic generic segment that provides an end-to-end gastrointestinal suite, integrating local manufacturing with high-performance prokinetic agents (such as Domperidone).

5. Thai Nakorn Patana Co., Ltd.

Combines manufacturing excellence with software-driven distribution, offering instant medication disbursements and automated statutory health payments in a single click.

6. Otsuka Pharmaceutical

Provides high-volume processing and clinical management solutions, supporting some of the largest private medical networks and electrolyte management systems in the country.

7. Unison Laboratories Co., Ltd.

Specializes in managed therapeutic systems and compliance, delivering reliable care for complex IT operations and innovative oral liquid drug frameworks.

8. Pfizer

Provides high-durability pharmaceutical hardware processing and system management solutions, supporting some of the largest industrial health frameworks in the country.

9. GlaxoSmithKline (GSK)

A global giant that leverages clinical trials and data to provide high-precision system processing for diverse gastrointestinal and immunological conditions.

Key Players in Thailand Gastroparesis Market: FAQs